Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Michael McDermott

Concepts (149)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hyperthyroidism
5
2020
26
1.750
Why?
Hypothyroidism
5
2020
65
1.660
Why?
Graves Disease
2
2020
34
0.760
Why?
Osteoporosis
5
2009
224
0.750
Why?
Triiodothyronine
3
2020
42
0.730
Why?
Thyroid Neoplasms
2
2020
271
0.720
Why?
Thyroxine
3
2020
57
0.660
Why?
Bone Density Conservation Agents
2
2009
62
0.590
Why?
Thyroid Diseases
4
2005
31
0.580
Why?
Hypoglycemic Agents
2
2016
1011
0.560
Why?
Thyrotoxicosis
2
2020
8
0.550
Why?
Vitamins
2
2008
150
0.530
Why?
Vitamin D
3
2008
340
0.520
Why?
Antithyroid Agents
4
2020
12
0.510
Why?
Iodine Radioisotopes
4
2020
126
0.490
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2012
43
0.390
Why?
Thyrotropin
4
2020
100
0.380
Why?
Vitamin D Deficiency
3
2009
158
0.370
Why?
Diabetes Mellitus, Type 2
2
2016
2087
0.370
Why?
Diagnosis, Differential
4
2020
1331
0.360
Why?
Patient Education as Topic
2
2015
666
0.310
Why?
Premenopause
1
2009
105
0.310
Why?
Thyroidectomy
2
2020
62
0.270
Why?
Thyroid Hormones
2
2020
53
0.260
Why?
Endocrinology
2
2004
71
0.260
Why?
Pharmacists
1
2008
231
0.260
Why?
Cardiovascular Diseases
1
2016
1726
0.250
Why?
Hormone Replacement Therapy
2
2020
76
0.240
Why?
Bone Density
4
2009
432
0.240
Why?
Hospitalization
2
2020
1762
0.240
Why?
Humans
28
2020
114045
0.230
Why?
Reproductive Medicine
1
2004
15
0.220
Why?
Professional Practice
1
2003
63
0.220
Why?
Blood Glucose
2
2016
1827
0.210
Why?
Thyrotropin, beta Subunit
1
2002
5
0.210
Why?
Insulin
2
2016
2080
0.200
Why?
Drug Therapy, Combination
2
2020
949
0.200
Why?
Diabetes Mellitus
2
2008
898
0.200
Why?
Point Mutation
1
2002
216
0.190
Why?
Hip Fractures
1
2003
75
0.190
Why?
Thyroid Gland
1
2002
85
0.190
Why?
Methimazole
1
2020
6
0.180
Why?
Myxedema
1
2020
1
0.180
Why?
Mass Screening
3
2020
979
0.170
Why?
Absorptiometry, Photon
3
2009
224
0.170
Why?
Diet
1
2007
1080
0.170
Why?
Risk Factors
5
2020
8614
0.170
Why?
Treatment Failure
1
2020
330
0.170
Why?
Female
16
2020
59324
0.160
Why?
Practice Guidelines as Topic
2
2020
1381
0.160
Why?
Physical Examination
1
2020
221
0.160
Why?
Reference Values
1
2020
739
0.160
Why?
Practice Patterns, Physicians'
2
2006
1175
0.150
Why?
Triiodothyronine, Reverse
1
2018
2
0.150
Why?
Thyroid Function Tests
1
2018
11
0.150
Why?
Adrenergic beta-Antagonists
1
2020
286
0.150
Why?
Hypoglycemia
2
2016
386
0.140
Why?
Parathyroid Hormone
2
2008
96
0.140
Why?
Biomarkers
2
2020
3397
0.130
Why?
Pregnancy Complications
1
2020
430
0.130
Why?
Referral and Consultation
1
2020
632
0.130
Why?
Insulin Antibodies
1
2016
102
0.120
Why?
Neoplasm Recurrence, Local
1
2020
850
0.120
Why?
Rituximab
1
2016
148
0.120
Why?
Aged
9
2016
18969
0.110
Why?
Immunologic Factors
1
2016
217
0.110
Why?
Ambulatory Care
2
2008
479
0.110
Why?
Pregnancy
3
2020
5499
0.110
Why?
Case-Control Studies
1
2020
3003
0.110
Why?
Sex Factors
2
2012
1706
0.110
Why?
Diabetes Complications
1
2015
208
0.110
Why?
Age Factors
2
2012
2885
0.100
Why?
Autoimmune Diseases
1
2016
381
0.100
Why?
Aged, 80 and over
3
2008
6306
0.100
Why?
Thyroid Crisis
1
2012
7
0.100
Why?
Retrospective Studies
3
2020
12521
0.100
Why?
Postpartum Thyroiditis
1
2011
1
0.090
Why?
Non-alcoholic Fatty Liver Disease
1
2015
244
0.090
Why?
Structure-Activity Relationship
1
2012
499
0.090
Why?
Drug Interactions
1
2012
337
0.090
Why?
Liver Diseases
1
2012
254
0.080
Why?
Risk
1
2012
810
0.080
Why?
Colorado
4
2009
4090
0.080
Why?
Male
10
2016
55396
0.080
Why?
Adipokines
1
2009
42
0.080
Why?
Obesity
2
2015
2505
0.080
Why?
Kidney Diseases
1
2012
349
0.080
Why?
Community-Institutional Relations
1
2009
89
0.080
Why?
Raloxifene Hydrochloride
1
2008
13
0.070
Why?
Patient Care
1
2008
99
0.070
Why?
Self Administration
1
2008
122
0.070
Why?
Diphosphonates
1
2008
51
0.070
Why?
Pilot Projects
2
2009
1360
0.070
Why?
Pharmaceutical Services
1
2008
76
0.070
Why?
Professional Role
1
2008
148
0.070
Why?
Women's Health
1
2009
270
0.070
Why?
Life Style
1
2009
428
0.070
Why?
Nutrition Policy
1
2007
54
0.070
Why?
Health Knowledge, Attitudes, Practice
1
2015
1168
0.070
Why?
Phosphorus
1
2007
81
0.070
Why?
Insulin Lispro
1
2006
34
0.070
Why?
Nonprescription Drugs
1
2007
68
0.070
Why?
Serum Albumin
1
2007
137
0.070
Why?
Body Composition
1
2009
590
0.060
Why?
Creatinine
1
2007
424
0.060
Why?
Quality of Health Care
1
2009
572
0.060
Why?
Middle Aged
6
2015
26605
0.060
Why?
Patient Compliance
1
2008
524
0.060
Why?
Fractures, Bone
1
2009
367
0.060
Why?
Outpatients
1
2007
325
0.060
Why?
Thyroid Nodule
1
2003
45
0.050
Why?
Densitometry
1
2003
29
0.050
Why?
Inpatients
1
2006
378
0.050
Why?
Hospitals, University
1
2003
169
0.050
Why?
Health Services for the Aged
1
2003
70
0.050
Why?
Medical Records
1
2003
153
0.050
Why?
Pulmonary Disease, Chronic Obstructive
1
2009
907
0.050
Why?
Exons
1
2002
301
0.050
Why?
Biopsy, Needle
1
2002
180
0.050
Why?
Calcium
1
2007
1089
0.050
Why?
Prevalence
1
2007
2247
0.050
Why?
Cross-Sectional Studies
2
2009
4402
0.040
Why?
Adenoma
1
2002
187
0.040
Why?
Follow-Up Studies
1
2008
4392
0.040
Why?
Base Sequence
1
2002
2114
0.040
Why?
Amino Acid Sequence
1
2002
1981
0.040
Why?
Exercise
1
2009
1642
0.040
Why?
Surveys and Questionnaires
2
2015
4595
0.040
Why?
Molecular Sequence Data
1
2002
2783
0.040
Why?
Risk Assessment
1
2006
2958
0.040
Why?
Patient Discharge
1
2003
770
0.030
Why?
Biomarkers, Tumor
1
2002
1032
0.030
Why?
Prospective Studies
1
2007
6195
0.030
Why?
Blood Glucose Self-Monitoring
1
2016
505
0.020
Why?
Adult
3
2015
30375
0.020
Why?
Severity of Illness Index
2
2009
2537
0.020
Why?
Resistin
1
2009
12
0.020
Why?
Biological Factors
1
2009
35
0.020
Why?
Medical Audit
1
2008
75
0.020
Why?
Hip Joint
1
2009
124
0.020
Why?
Leptin
1
2009
210
0.020
Why?
Adiponectin
1
2009
213
0.020
Why?
Lumbar Vertebrae
1
2009
207
0.020
Why?
Body Mass Index
1
2015
1957
0.020
Why?
Insulin Resistance
1
2015
1072
0.020
Why?
Program Evaluation
1
2008
820
0.010
Why?
Tumor Necrosis Factor-alpha
1
2009
1128
0.010
Why?
Treatment Outcome
1
2016
9049
0.010
Why?
Lung
1
2009
3521
0.010
Why?
McDermott's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)